Top View
- Toxicological Profile for Arsenic
- Combination Chemotherapy with Docetaxel, Vinorelbine and Estramustine Phosphate in Metastatic Androgen-Resistant Prostate Cancer: a Single Institution Experience
- Dbl Cisplatin Injection Data Sheet
- Systematic Review and Meta-Analysis of in Vitro Anti-Human Cancer Experiments Investigating the Use of 5-Aminolevulinic Acid (5-ALA) for Photodynamic Therapy
- Arsenic Trioxide Sensitivity Is Associated with Low Level Of
- 5-Aminolevulinic Acid Protects Against Cisplatin-Induced Nephrotoxicity Without Compromising the Anticancer Efficiency of Cisplatin in Rats in Vitro and in Vivo
- Inp- VTD-PACE (IV) Bortezomib
- The Cisplatin-Derived Increase of Mitochondrial Reactive Oxygen Species Enhances the Effectiveness of Photodynamic Therapy Via Transporter Regulation
- Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local Or Metastatic Esophageal Cancer
- Therapeutic Role of Arsenic Trioxide in Cancer Protection Archana Chaudhary and Rizwanul Haque*
- Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin As the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
- LUNG CANCER TREATMENT REGIMENS (Part 1 of 7) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
- DRUG NAME: Cisplatin
- Association of High-Dose Cyclophosphamide, Cisplatin, And
- BC Cancer Protocol Summary for Adjuvant Therapy for Osteosarcoma Using Doxorubicin and Cisplatin
- Cisplatin Doxorubicin Sarcoma
- Protocol: Doxorubicin/Cisplatin Indications: Osteosarcoma
- Pdf 841.59 K
- Arsenic Trioxide Enhances the Cytotoxic Effect of Cisplatin in Head and Neck Squamous Cell Carcinoma Cell Lines
- Cisplatin Versus Carboplatin: Comparative Review of Therapeutic Management in Solid Malignancies
- BC Cancer Protocol Summary for Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck Cancer Using Fluorouracil and Platinum
- Efficacy and Safety Analysis of Oxaliplatin-Based Chemotherapy
- Gastric Cancer Treatment Regimens
- Cervical Cancer Treatment Regimens
- (Ddmvac) with Gemcitabine and Cisplatin (GC) As Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis
- HEAD and NECK CANCER TREATMENT REGIMENS (Part 1 of 5)
- Cyclophosphamide, Cisplatin and Doxorubicin (CAP)
- Cyclophosphamide
- Inhibition of Malignant Glial Cell Growth by Estramustine, an Estrogen
- Β-Catenin Signalling and Mre11–Rad50–Nbs1 Complex in the Repair of Cisplatin-Induced DNA Cross-Links
- Cisplatin Injection
- Platinum Derivatives Effects on Anticancer Immune Response
- Resistance Mechanisms Following Cisplatin and Oxaliplatin Treatment of the Human Teratocarcinoma Cell Line 2102EP
- Cisplatin Doxorubicin Methotrexate Vinblastine (Accelerated) Ver1.1
- 5-Aminolevulinic Acid Photodynamic Therapy in Human Cervical Cancer Via the Activation of Microrna-143 and Suppression of the Bcl-2/Bax Signaling Pathway
- Treatment of Patients with Advanced Biliary Tract Cancer with Either
- Effects of Different Combined Regimens of Cisplatin, Metformin, And
- Phase I Study of Doxil-Cisplatin Combination Chemotherapy in Patients with Advanced Malignancies1
- A Patient with Scirrhous Stomach Cancer Treated with Combination of Hyperthermotherapy and 5-Aminolevulinic Acid (ALA)
- Safety and Efficacy of Weekly Paclitaxel and Cisplatin
- (SCLC) with Cisplatin and Etoposide
- Presentation of Research Paper on 5-ALA by Kochi University to Plos ONE, a U.S
- (12) United States Patent (10) Patent No.: US 6,436,913 B1 Asp (45) Date of Patent: Aug